Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13295
Abstract: Mutations in the VAV1 guanine nucleotide exchange factor 1 have been recently found in peripheral T cell lymphoma and nonsmall‐cell lung cancer (NSCLC). To understand their pathogenic potential, we generated a gene‐edited mouse model that…
read more here.
Keywords:
vav1;
edited mouse;
gene edited;
gene ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "STEM CELLS"
DOI: 10.1002/stem.2760
Abstract: During bone marrow transplantation, hematopoietic stem and progenitor cells (HSPCs) respond to signals from the hematopoietic microenvironment by coordinately activating molecular pathways through Rho GTPases, including Rac. We have previously shown that deletion of Vav1,…
read more here.
Keywords:
irradiated recipients;
stem progenitor;
hematopoietic stem;
hspcs ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Oncogene"
DOI: 10.1038/onc.2016.378
Abstract: The highly homeostasis-resistant nature of cancer cells leads to their escape from treatment and to liver metastasis, which in turn makes pancreatic ductal adenocarcinoma (PDAC) difficult to treat, especially the squamous/epithelial-to-mesenchymal transition (EMT)-like subtype. As…
read more here.
Keywords:
promotes mesenchymal;
cancer cells;
cancer;
vav1 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "ESMO Open"
DOI: 10.1136/esmoopen-2018-eacr25.714
Abstract: Introduction The overall 5 year survival rate of Pancreatic Ductal Adenocarcinoma (PDAC) is less than 5% and has remained stubbornly unchanged long time ago, despite the efforts in preclinical and clinical science. PDAC, the main form…
read more here.
Keywords:
vav1;
pdac;
mutant ras;
vav1 rasg12d ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-124591
Abstract: Background: VAV1 is known as an important mediator of T-cell receptor (TCR) signaling through its guanine exchange factor (GEF)-dependent and independent functions. Recent studies identified activating VAV1 mutations in several types of T-cell malignancies including…
read more here.
Keywords:
mice;
vav1 mutants;
cell;
vav1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Journal of Cell Science"
DOI: 10.1242/jcs.238337
Abstract: ABSTRACT Vav family guanine nucleotide exchange factors (GEFs) are essential regulators of immune function. Despite their structural similarity, Vav1 promotes and Vav2 opposes T cell receptor (TCR)-induced Ca2+ entry. By using a Vav1-deficient Jurkat T…
read more here.
Keywords:
vav2;
scaffolding functions;
cell activation;
vav1 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12060993
Abstract: Triple negative breast cancer (TNBC) represents the most aggressive breast tumor, showing a high intrinsic variability in terms of both histopathological features and response to therapies. Blocking the Akt signaling pathway is a well-studied approach…
read more here.
Keywords:
mir 29b;
vav1;
triple negative;
breast tumors ... See more keywords